Search research articles
Contact Us
Filters
Showing results (211-220 of 237) with videos related to
Page
of 24
Sort By:
Scientific Reports
|
July 2, 2025
Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment
Sravya V Bhamidipati, Anil Surathu, Hsu Chao, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment
Sravya V Bhamidipati, Anil Surathu, Hsu Chao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Christina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Vaccine
|
January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Hana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Science Translational Medicine
|
February 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
Noemia S Lima, Lauren McCormick, Samuel Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
Nicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2023
Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia
Lauren M Schwartz, Jennifer Oshinsky, Mardi Reymann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Angela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
The Journal of Infectious Diseases
|
April 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
Robert L Atmar, Kirsten E Lyke, Christine M Posavad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Nadine G Rouphael, Angela R Branche, David J Diemert, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 237) with videos related to
Sort By:
Page
of 24
Scientific Reports
|
July 2, 2025
Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment
Sravya V Bhamidipati, Anil Surathu, Hsu Chao, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment
Sravya V Bhamidipati, Anil Surathu, Hsu Chao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Christina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Vaccine
|
January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Hana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Science Translational Medicine
|
February 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
Noemia S Lima, Lauren McCormick, Samuel Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
Nicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2023
Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia
Lauren M Schwartz, Jennifer Oshinsky, Mardi Reymann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Angela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
The Journal of Infectious Diseases
|
April 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
Robert L Atmar, Kirsten E Lyke, Christine M Posavad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Nadine G Rouphael, Angela R Branche, David J Diemert, et al.
Page
of 24